126 related articles for article (PubMed ID: 32559532)
1. Liquid-liquid extraction as a simple tool to quickly quantify fourteen cytostatics in urban wastewaters and access their impact in aquatic biota.
Gouveia TIA; Silva AMT; Ribeiro AR; Alves A; Santos MSF
Sci Total Environ; 2020 Oct; 740():139995. PubMed ID: 32559532
[TBL] [Abstract][Full Text] [Related]
2. Multi-target analysis of cytostatics in hospital effluents over a 9-month period.
Gouveia TIA; Silva AMT; Freire MG; Sousa ACA; Alves A; Santos MSF
J Hazard Mater; 2023 Apr; 448():130883. PubMed ID: 36731320
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry.
Gómez-Canela C; Ventura F; Caixach J; Lacorte S
Anal Bioanal Chem; 2014 Jun; 406(16):3801-14. PubMed ID: 24825763
[TBL] [Abstract][Full Text] [Related]
4. Development of an analytical methodology for the analysis of priority cytostatics in water.
Santos MSF; Franquet-Griell H; Alves A; Lacorte S
Sci Total Environ; 2018 Dec; 645():1264-1272. PubMed ID: 30248851
[TBL] [Abstract][Full Text] [Related]
5. New insights on cytostatic drug risk assessment in aquatic environments based on measured concentrations in surface waters.
Gouveia TIA; Alves A; Santos MSF
Environ Int; 2019 Dec; 133(Pt B):105236. PubMed ID: 31675568
[TBL] [Abstract][Full Text] [Related]
6. Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: filtration, occurrence, and environmental risk.
Negreira N; de Alda ML; Barceló D
Sci Total Environ; 2014 Nov; 497-498():68-77. PubMed ID: 25124055
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry.
Gómez-Canela C; Cortés-Francisco N; Oliva X; Pujol C; Ventura F; Lacorte S; Caixach J
Environ Sci Pollut Res Int; 2012 Sep; 19(8):3210-8. PubMed ID: 22382696
[TBL] [Abstract][Full Text] [Related]
8. Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain).
Franquet-Griell H; Gómez-Canela C; Ventura F; Lacorte S
Environ Res; 2015 Apr; 138():161-72. PubMed ID: 25721243
[TBL] [Abstract][Full Text] [Related]
9. Are cytostatic drugs in surface waters a potential threat?
Gouveia TIA; Mota IH; Silva AMT; Alves A; Santos MSF
Sci Total Environ; 2022 Dec; 853():158559. PubMed ID: 36087660
[TBL] [Abstract][Full Text] [Related]
10. Ozonation of cytostatic drugs in aqueous phase.
Garcia-Costa AL; Gouveia TIA; Pereira MFR; Silva AMT; Alves A; Madeira LM; Santos MSF
Sci Total Environ; 2021 Nov; 795():148855. PubMed ID: 34247083
[TBL] [Abstract][Full Text] [Related]
11. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
Kosma CI; Lambropoulou DA; Albanis TA
Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
[TBL] [Abstract][Full Text] [Related]
12. On-line solid phase extraction-liquid chromatography-tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples.
Negreira N; López de Alda M; Barceló D
J Chromatogr A; 2013 Mar; 1280():64-74. PubMed ID: 23357749
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous and systematic analysis of cytostatic drugs in wastewater samples by ultra-high performance liquid chromatography tandem mass spectrometry.
Santana-Viera S; Hernández-Arencibia P; Sosa-Ferrera Z; Santana-Rodríguez JJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():124-132. PubMed ID: 30807965
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of non-steroidal anti-inflammatory drugs in Tehran source water, municipal and hospital wastewaters, and their ecotoxicological risk assessment.
Eslami A; Amini MM; Yazdanbakhsh AR; Rastkari N; Mohseni-Bandpei A; Nasseri S; Piroti E; Asadi A
Environ Monit Assess; 2015 Dec; 187(12):734. PubMed ID: 26553436
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of selected pharmaceuticals in wastewater treatment plants of Tuscany: An effect-based approach to evaluate the potential environmental impact.
Palli L; Spina F; Varese GC; Vincenzi M; Aragno M; Arcangeli G; Mucci N; Santianni D; Caffaz S; Gori R
Int J Hyg Environ Health; 2019 May; 222(4):717-725. PubMed ID: 31101503
[TBL] [Abstract][Full Text] [Related]
16. Optimization and application of fabric phase sorptive extraction coupled to ultra-high performance liquid chromatography tandem mass spectrometry for the determination of cytostatic drug residues in environmental waters.
Santana-Viera S; Guedes-Alonso R; Sosa-Ferrera Z; Santana-Rodríguez JJ; Kabir A; Furton KG
J Chromatogr A; 2017 Dec; 1529():39-49. PubMed ID: 29132820
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical pollution of hospital effluents and municipal wastewaters of Eastern Canada.
Vaudreuil MA; Vo Duy S; Munoz G; Sauvé S
Sci Total Environ; 2022 Nov; 846():157353. PubMed ID: 35842153
[TBL] [Abstract][Full Text] [Related]
18. Tracking the occurrence of psychotropic pharmaceuticals in Brazilian wastewater treatment plants and surface water, with assessment of environmental risks.
Pivetta RC; Rodrigues-Silva C; Ribeiro AR; Rath S
Sci Total Environ; 2020 Jul; 727():138661. PubMed ID: 32334225
[TBL] [Abstract][Full Text] [Related]
19. Two synthetic progestins and natural progesterone are responsible for most of the progestagenic activities in municipal wastewater treatment plant effluents in the Czech and Slovak republics.
Šauer P; Stará A; Golovko O; Valentová O; Bořík A; Grabic R; Kroupová HK
Water Res; 2018 Jun; 137():64-71. PubMed ID: 29544204
[TBL] [Abstract][Full Text] [Related]
20. Contributions towards the hazard evaluation of two widely used cytostatic drugs.
Monteiro B; Venâncio C; Francisco R; Sousa ACA; Lopes I
Environ Sci Pollut Res Int; 2023 Feb; 30(6):15641-15654. PubMed ID: 36169838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]